×

BioCorRx, Inc. Announces Distribution Rights in Ohio for Start Fresh Program

BioCorRx logo

Los Angeles, July 1, 2014 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (OTCQB: BICX), a leader in addiction treatment and rehabilitation programs, announced it has closed another sale for the exclusive license and distribution rights of its Start Fresh Program to Sobriety and Addictions Solutions, LLC. Under the terms of the agreement, Sobriety and Addictions Solutions has paid BioCorRx, Inc. an upfront licensing fee and will also pay an upfront fee per program ordered in the state of Ohio. The closing of the Ohio territory marks the third transaction between Sobriety and Addictions Solutions, LLC and BioCorRx, Inc. The previous two transactions included the combined areas of Northern California, North Carolina, Maryland, Virginia, West Virginia, and Washington D.C.

The population of Ohio is just over 11.5 million people and the state is uniquely situated in that it is within only one day's drive of 50% of all of North America's population. Bringing the Start Fresh Program to Ohio gives hope not only to residents of the state, but to those within driving distance as well. Ohio recently saw a 24% increase in drunk driving deaths according to MADD and binge drinking rates in the state have been on a steady incline over the last decade. A new study just released by the Centers for Disease Control found that excessive drinking, both regular heavy drinking and occasional binge drinking, cause 1 in 10 deaths of working age adults. According to the study's findings alcohol abuse is now the third largest preventable cause of death in this age group, which cut an average of 30 years off the lives of those who died. Ohio has also been a victim of the opiate epidemic that has been grabbing national attention in recent years. One county saw the number of heroin deaths increase four fold in just a four-year period.

"We are very pleased with this latest license deal as it will broaden access to the Start Fresh Program in yet another state with dismal drug and alcohol abuse statistics. This group is helping patients regularly in their two Northern California locations found in the San Francisco metro area and Fresno. They are also working diligently at getting their Washington D.C. clinic open soon. We are pleased that the success they are seeing in their clinics is pushing them to expand quickly," said Kent Emry, CEO of BioCorRx, Inc. "Broadening our reach further throughout the Midwest is yet another step towards our goal of making the Start Fresh Program available to everyone, regardless of their location."

Media

Click here to view Recent National Television Media on the BioCorRx YouTube Channel

Click here for company Facebook page for more stories and media coverage

About BioCorRx, Inc.

BioCorRx, Inc. (OTCQB: BICX) is an addiction treatment and rehabilitation company on the leading edge of addiction treatment. The company has developed a highly effective program called the Start Fresh ProgramTM consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions. For more information on BICX, visit www.BioCorRx.com.

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

CONTACT: Investor Relations SmallCapVoice.com, Inc. 512-267-2430

Source:BioCorRx